EntrepreneurialCheck
Daniel Storgaard estimated net worth profile

Daniel Storgaard net worth

Daniel Storgaard Net Worth 2026 (Estimated) · Founder at Reshape Biotech · YC W21
est. wealth $18.67M

Quick answer

Daniel Storgaard's estimated net worth is $18.67M (range $13.07M – $28.0M) as of 2026. Daniel Storgaard is Founder at Reshape Biotech. Reshape Biotech valuation.

Daniel Storgaard is Founder at Reshape Biotech (YC W21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameDaniel Storgaard
RoleFounder
CompanyReshape Biotech
YC batchW21
Est. company val$200.0M
Assumed ownership9.3%
Est. paper wealth / net worth$18.67M
$13.07M – $28.0M

Who is Daniel Storgaard?

Daniel Storgaard is a founder at Reshape Biotech, which is part of Y Combinator's Winter 2021 batch.

Highlights:

  • Y Combinator W21
  • Reshape Biotech

About Reshape Biotech

Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images. Other companies try to sell “one lab robot that does everything”. But those robots become so complicated that they sit unused on the shelf. We build one robot for each function, which makes them easy to use.

FAQ: Daniel Storgaard net worth and Reshape Biotech valuation

What is Daniel Storgaard's net worth?

Daniel Storgaard's estimated net worth is $18.67M (range $13.07M – $28.0M) as of 2026. Daniel Storgaard is Founder at Reshape Biotech. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Reshape Biotech valuation?

Reshape Biotech's estimated valuation on Entrepreneurial Check is $200.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Daniel Storgaard's role?

Daniel Storgaard is Founder at Reshape Biotech, a Y Combinator-backed startup (batch W21).